skip to Main Content
Home » UK Shares » AIM Risers and Fallers » AIM round-up: Sabien Technologies, Pipehawk, Image Scan

AIM round-up: Sabien Technologies, Pipehawk, Image Scan


London’s AIM index may have only seen modest losses on Wednesday but that makes for a seventh consecutive day of declines. At the bell the market was down just over three points at 1274.89

  • Sabien Technologies +93%
  • Pipehawk +16%
  • Character Group -15%
  • Renalytix -12%
  • Image Scan -10%

Sabien Technologies [LND:SNT] made a sound impression, adding some 93% by the bell. The company announced a sales agency agreement this morning, giving it exclusive rights to sell the technology of a Korean company, City Oil Field, which provides innovative ways to reduce waste exports and also sending rubbish to landfill. Volumes were recorded at more than 14 million shares trading hands, almost as many as are in circulation!

Pipehawk [LND:PIP] came in second place, but with gains limited to just 16% it was a fair way off the pace. There’s no firm news out, but interest in the stock has been elevated. The 7% spread also needs to be taken into account.

Character Group [LND:CCT] was the day’s worst performer, off some 15% in the wake of a trading update. There’s nothing of great consequence in this, other than an acknowledgement that global supply chain issues are likely to weigh on full year profitability, although knocking no more than 10% off expectations.

Renalytix [LND:RENX] is on the radar again, shedding 12%. A regulatory update after the close last night is resulting in some delays for the business, although the company doesn’t believe this will result in a material impact. With the shares having bounced off lows shortly after the open, the downside here may be exhausted already.

A notable mention for Image Scan [LON:IGE] who have been on our radar for the last few days. Shares slipped 10% today, giving back yesterday’s gains but still holding onto the upside accrued off the back of that trading update on Monday.

Like this article? Get more of the same with our daily newsletter. Or get the weekly version here.

This article does not constitute investment advice. Do your own research or consult a professional advisor.

Stocks in Focus

We think these smaller companies represent significant growth stories. Read our in-depth reports.

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

FP Markets
Back To Top